Axsome (AXSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Axsome Therapeutics (AXSM) reported $121.46 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 62$0.80 for the same period compares to -$1.09 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$119.49 million, representing a surprise of +1.66%. The company delivered an EPS surprise of +36.51%, with the consensus EPS estimate being -$1.26.While investors scrutinize revenue and earnings changes year-over-year and how they compare ...